Therapeutic efficacy of sonic hedgehog protein in experimental diabetic neuropathy

Journal of Clinical Investigation

Volumn 111, Issue 4, 2003, Pages 507-514

  Calcutt, Nigel A ^a   Allendoerfer, Karen L ^b   Mizisin, Andrew P ^a   Middlemas, Alicia ^c   Freshwater, Jason D ^a   Burgers, Monica ^a   Ranciato, Rigel ^b   Delcroix, Jean Dominique ^c   Taylor, Frederick R ^d   Shapiro, Renee ^d   Strauch, Kathy ^d   Dudek, Henryk ^b   Engber, Thomas M ^d   Galdes, Alphonse ^d   Rubin, Lee L ^b   Tomlinson, David R ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CURIS INC   (United States)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; HYBRID PROTEIN; IMMUNOGLOBULIN G; MESSENGER RNA; NERVE GROWTH FACTOR; NEUROPEPTIDE Y; SONIC HEDGEHOG PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BRAIN MATURATION; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; EMBRYO DEVELOPMENT; HYPOALGESIA; MALE; MOTOR NERVE; MYELINATED NERVE; NERVE CONDUCTION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SCIATIC NERVE; SENSORY NERVE;

ANIMALS; DIABETIC NEUROPATHIES; HEDGEHOG PROTEINS; HUMANS; IMMUNOGLOBULIN G; MALE; NEURAL CONDUCTION; RATS; RATS, WISTAR; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; SCIATIC NERVE; TRANS-ACTIVATORS;

EID: 0037329984     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200315792     Document Type: Article

References (48)

1. Bitgood, M.J., and McMahon, A.P. 1995. Hedgehog and BMP genes are coexpressed at many diverse sites of cell-cell interaction in the mouse embryo. Dev. Biol. 172:126-138.
2. Roelink, H., et al. 1994. Floor plate and motor neuron induction by Vhh-1, a vertebrate homologue of hedgehog expressed by the notochord. Cell. 76:761-775.
3. Wang, M.Z., et al. 1995. Induction of the dopaminergic neuron phenotype in the midbrain by sonic hedgehog protein. Nat. Med. 1:1184-1188.
4. Chiang, C., et al. 1996. Cyclopia and defective patterning in mice lacking sonic hedgehog gene function. Nature. 383:407-413.
5. Goodrich, L., and Scott, M. 1998. Hedgehog and patched in neural development and disease. Neuron. 21:1243-1257.
6. Parmantier, E., et al. 1999. Schwann cell-derived desert hedgehog controls the development of peripheral nerve sheaths. Neuron. 23:713-724.
7. Umehara, F., et al. 2000. A novel mutation of desert hedgehog in a patient with 46,XY partial gonadal dysgenesis accompanied by mini-fascicular neuropathy. Am. J. Hum. Genet. 67:1302-1305.
8. Berg, A., et al. 2000. Upregulation of desert hedgehog and hedgehog signaling during peripheral nerve regeneration. Soc. Neurosci. (Abstracts on CD-ROM). Abstr. 25; program no. 792.13.
9. Engber, T.M., et al. 2000. Sonic hedgehog improves functional recovery following sciatic nerve crush injury. Soc. Neurosci. (Abstracts on CD-ROM). Abstr. 25; program no. 792.14.
10. Pola, R., et al. 2001. The morphogen sonic hedgehog is an indirect angiogenic: agent upregulating two families of angiogenic growth factors. Nat. Med. 7:706-711.
11. Johnson, P.C., Brendel, K., and Meezan, E. 1981. Human diabetic perineurial cell basement membrane thickening. Lab. Invest. 44:265-270.
12. Ghani, M., et al. 1999. Perineurial abnormalities in the spontaneously diabetic dog. Acta Neuropathol. 97:98-102.
13. Pitre, D.A., Seifert, J.L., and Bauer, J.A. 2001. Perineurium inflammation and altered connexin isoform expression in a rat model of diabetes related peripheral neuropathy. Neurosci. Lett. 303:67-71.
14. Rechthand, E., Smith, Q.R., Latker, C.H., and Rapoport, S.I. 1987. Altered blood-nerve barrier permeability to small molecules in experimental diabetes mellitus. J. Neuropathol. Exp. Neurol. 46:302-314.
15. Taylor, F.R., et al. 2001. Enhanced potency of human sonic hedgehog by hydrophobic modification. Biochemistry. 40:4359-4371.
16. Calcutt, N.A., et al. 1999. Prosaposin gene expression and the efficacy of a prosaposin-derived peptide in preventing structural and functional disorders of peripheral nerve in diabetic rats. J. Neuropathol. Exp. Neurol. 58:628-636.
17. Calcutt, N.A., Li, L., Yaksh, T.L., and Malmberg, A.B. 1995. Different effects of two aldose reductase inhibitors on nociception and prostaglandin E. Eur. J. Pharmacol. 285:189-197.
18. Calcutt, N.A., Mizisin, A.P., and Kalichman, M.W. 1994. Aldose reductase inhibition, Doppler flux and conduction in diabetic rat nerve. Eur. J. Pharmacol. 251:27-33.
19. Fernyhough, P., et al. 1995. Human recombinant nerve growth factor replaces deficient neurotrophic support in the diabetic rat. Eur. J. Neurosci. 7:1107-1110.
20. Malcangio, M., Garrett, N.E., and Tomlinson, D.R. 1995. Nerve growth factor treatment increases stimulus-evoked release of sensory neuropeptides in the rat spinal cord. Eur. J. Neurosci. 9:1101-1104.
21. Mizisin, A.P., et al. 1997. BDNF attenuates functional and structural disorders in nerves of galactose-fed rats. J. Neuropathol. Exp. Neurol. 56:1290-1301.
22. Weibel, E.R. 1979. Stereological methods. Academic Press. New York, New York, USA. 415 pp.
23. Mizisin, A.P., Steinhardt, R.C., O'Brien, J.S., and Calcutt, N.A. 2001. TX14(A), a prosaposin-derived peptide, reverses established nerve disorders in streptozotocin-diabetic rats and prevents them in galactosefed rats. J. Neuropathol. Exp. Neurol. 60:953-960.
24. Echelard, Y., et al. 1993. Sonic hedgehog, a member of a family of putative signaling molecules, is implicated in the regulation of CNS polarity. Cell. 75:1417-1430.
25. Calcutt, N.A., Muir, D., Powell, H.C., and Mizisin, A.P. 1992. Reduced ciliary neuronotrophic factor-like activity in nerves from diabetic or galactose-fed rats. Brain Res. 575:320-324.
26. Kalichman, M.W., Powell, H.C., and Mizisin, A.P. 1998. Reactive, degenerative, and proliferative Schwann cell responses in experimental galactose and human diabetic neuropathy. Acta Neuropathol. 95:47-56.
27. Mizisin, A.P., Shelton, G.D., Wagner, S., Rusbridge, C., and Powell, H.C. 1998. Myelin splitting, Schwann cell injury and demyelination in feline diabetic neuropathy. Acta Neuropathol. 95:171-174.
28. Pepinsky, R.B., et al. 2002. Long-acting forms of sonic hedgehog with improved pharmacokinetic and pharmacodynamic properties are efficacious in a nerve injury model. J. Pharmaceut. Sci. 91:371-387.
29. Pathi, S., et al. 2001. Comparative biological responses to human sonic, indian, and desert hedgehog. Mech. Dev. 106:107-117.
30. Cameron, N.E., Eaton, S.E., Cotter, M.A., and Tesfaye, S. 2001. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia. 44:1973-1988.
31. Friede, R., and Samorajski, T. 1970. Axon caliber related to neurofilaments and microtubules in sciatic nerve. Anat. Rec. 167:379-387.
32. Hoffman, P.N., et al. 1987. Neurofilament gene expression: a major determinant of axonal caliber. Proc. Natl. Acad. Sci. USA. 84:3472-3476.
33. Nixon, R.A., Paskevich, P.A., Sihag, R.K., and Thayer, C.Y. 1994. Phosphorylation on carboxyl terminus domains of neurofilament proteins in retinal ganglion cell neurons in vivo: influences on regional neurofilament accumulation, interfilament spacing and axonal caliber. J. Cell Biol. 126:1031-1046.
34. Sanchez, I., et al. 2000. Local control of neurofilament accumulation during radial growth of myelinating axons in vivo: selective role of sitespecific phosphorylation. J. Cell Biol. 151:1013-1024.
35. Medori, R., Autilio-Gambetti, L., Monaco, S., and Gambetti, P. 1985. Experimental diabetic neuropathy: impairment of slow transport with changes in axon cross-sectional area. Proc. Natl. Acad. Sci. USA. 82:7716-7720.
36. Fernyhough, P., et al. 1999. Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy. Diabetes. 48:881-889.
37. Yagihashi, S., Kamijo, M., and Watanabe, K. 1990. Reduced myelinated fiber size correlates with loss of axonal neurofilaments in peripheral nerve of chronically streptozotocin diabetic rats. Am. J. Pathol. 136:1365-1373.
38. Scott, J.N., Clark, A.W., and Zocodne, D.W. 1999. Neurofilament gene expression in progressive experimental diabetes: failure of synthesis and export by sensory neurons. Brain. 122:2109-2117.
39. de Waegh, A.M., Lee, V.M.-Y., and Brady, S.T. 1992. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell. 68:451-463.
40. Tomlinson, D.R., Fernyhough, P., and Diemel, L.T. 1997. Role of neurotrophins in diabetic neuropathy and treatment with nerve growth factors. Diabetes. 46(Suppl. 2):S43-S49.
41. Shadiack, A.M., Sun, Y., and Zigmond, R.E. 2001. Nerve growth factor antiserum induces axotomy-like changes in neuropeptide expression in intact sympathetic and sensory neurons. J. Neurosci. 21:363-371.
42. Hounsom, L., Corder, R., Patel, J., and Tomlinson, D.R. 2001. Oxidative stress participates in the breakdown of neuronal phenotype in experimental diabetic neuropathy. Diabetologia, 44:424-428.
43. Hellweg, R., and Hartung, H.D. 1990. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy. J. Neurosci. Res. 26:258-267.
44. Schmidt, R.E., et al. 2000. Effect of streptozotocin-induced diabetes on NGF, P75(NTR) and TtkA content of prevertebral and paravertebral rat sympathetic ganglia. Brain Res. 867:149-156.
45. Allendoerfer, K.L., Taratuska, A., and Drake, E.J. 2001. Sciatic nerve periand endoneurial fibroblasts respond to hedgehog in vitro. Soc. Neurosci. (Abstracts on CD-ROM). Abstr. 26; program no. 351.9.
46. Ishii, D.N. 1995. Implication of insulin-like growth factors in the pathogenesis of diabetic neuropathy. Brain Res. Brain Res. Rev. 20:47-67.
47. Raychaudhuri, S.P., Jiang, W.Y., and Farber, E.M. 1998. Psotiatic keratinocytes express high levels of nerve growth factor. Acta Derm. Venereol. 78:84-86.
48. Oro, A.E., et al. 1997. Basal cell carcinomas in mice overexpressing sonic hedgehog. Science. 276:817-821.